Status:

COMPLETED

Effect of Hydration Guided by Vigileo on the Prevention of CIN After PCI for Patients With AMI

Lead Sponsor:

Chinese PLA General Hospital

Collaborating Sponsors:

Lu jiang hospital

Conditions:

Myocardial Infarction

Contrast-induced Nephropathy

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

In this study, Vigileo is used to guide hydration adjustment, and SCr is used to estimate renal function. The aim of the study is to investigate the preventive effect of adequate hydration guided by V...

Detailed Description

This study was conducted in patients with acute myocardial infarction who undergo emergency PCI in Chinese PLA General Hospital. The patients were randomly divided into two groups: the adequate hydrat...

Eligibility Criteria

Inclusion

  • Clearly diagnosed STEMI or NSTEMI patients:
  • Patients aged 18-80 years
  • Patients are scheduled to undergo emergency percutaneous coronary interventions
  • Estimated glomerular filtration rate eGFR \<120ml / min (according to MDRD formula)
  • Sign the informed consent to join the group.

Exclusion

  • Patients with mechanical complications
  • Patients with cardiogenic shock
  • Patients with aortic dissection
  • Patients who have malignant tumors or short-term progressive diseases that researchers believe improper to be included in the group
  • Hemodialysis-dependent patients with end-stage renal failure
  • Patients who had a history of exposure to radioactive contrast media within 1 week before or 72 hours after direct PCI
  • Patients who are allergic to radioactive contrast agents
  • Patients diagnosed with right ventricular myocardial infarction with hypotension (defined as systolic blood pressure ≤90 mmHg) on admission.

Key Trial Info

Start Date :

July 10 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 21 2022

Estimated Enrollment :

344 Patients enrolled

Trial Details

Trial ID

NCT04382313

Start Date

July 10 2020

End Date

December 21 2022

Last Update

January 4 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chinese People's Liberation Army General Hospital

Beijing, Beijing Municipality, China, 100853